China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE:300294)

China flag China · Delayed Price · Currency is CNY
17.72
+0.15 (0.85%)
Apr 29, 2026, 3:04 PM CST
-33.11%
Market Cap 8.86B
Revenue (ttm) 1.84B
Net Income (ttm) 3.44M
Shares Out 504.25M
EPS (ttm) 0.01
PE Ratio 2,579.16
Forward PE 24.07
Dividend 0.22 (1.24%)
Ex-Dividend Date n/a
Volume 3,500,401
Average Volume 4,518,824
Open 18.50
Previous Close 17.57
Day's Range 17.49 - 18.50
52-Week Range 17.40 - 27.99
Beta 0.34
RSI 31.61
Earnings Date Apr 25, 2026

About SHE:300294

China Resources Boya Bio-pharmaceutical Group Co.,Ltd engages in the research, development, production, and sale of blood products in China. It offers blood products, such as human serum albumin; human, intravenous, freeze-dried intravenous, hepatitis B, tetanus, and rabies immunoglobulin; and human fibrinogen, prothrombin complex, and coagulation factor VIII. The company also provides compound bone peptide, oxytocin, heparin sodium injection, posterior pituitary, and carboprost tromethamine injection. In addition, it engages in research, devel... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1993
Employees 1,947
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300294
Full Company Profile

Financial Performance

In 2025, SHE:300294's revenue was 2.06 billion, an increase of 18.69% compared to the previous year's 1.73 billion. Earnings were 112.70 million, a decrease of -71.61%.

Financial Statements

News

There is no news available yet.